Exploiting the Immunomodulatory Properties of Chemotherapeutic Drugs to Improve the Success of Cancer Immunotherapy

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2015.00516
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Determinants of Cancer Immunotherapy Success

Expert Review of Vaccines
Molecular MedicineDrug DiscoveryImmunologyPharmacology
2010English

Combining Microenvironment Normalization Strategies to Improve Cancer Immunotherapy

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2020English

Synthetic RNA-Based Immunomodulatory Gene Circuits for Cancer Immunotherapy

Cell
BiochemistryGeneticsMolecular Biology
2017English

Unleashing the Tiger – Iatrogenic Autoimmunity From Cancer Immunotherapy Drugs

JRSM Open
2018English

The Present Status of Chemotherapeutic and Antibiotic Drugs

Postgraduate Medical Journal
Medicine
1951English

The Immunomodulatory Properties of Amniotic Cells

Cell Transplantation
TransplantationBiomedical EngineeringCell Biology
2018English

Targeting the Immunomodulatory CD73/Adenosine System to Improve the Therapeutic Gain of Radiotherapy

Frontiers in Immunology
AllergyImmunology
2019English

Exploiting the TRIP-Br Family of Cell Cycle Regulatory Proteins as Chemotherapeutic Drug Targets in Human Cancer

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2007English

Mice No Longer Immune to Immunomodulatory Drugs

Blood
BiochemistryImmunologyCell BiologyHematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy